Daily non-political popular news in brief.
Testing the taser on human subjects -- preliminary physiological measurements
05-16-2007 · EurekAlert!There has been some controversy regarding the use of the Taser in controlling subjects in police custody, including reports of deaths. In a paper to be presented at the 2007 Society for Academic Emergency Medicine Annual Meeting, preliminary results of Taser exposure on healthy subjects will show that no short-term effects were observed.
Read more »
Keywords: testing, taser, human, subjects, preliminary, physiological, measurements, subject, measurement
« Previous | Next »
Similar news on "Testing the taser on human subjects -- preliminary physiological measurements":
- New mangosteen research establishes xanthone measurement standard
06-22-2007 · EurekAlert!
Prior to this study, there was no single-lab validated standard for xanthone identification and measurement in its naturally occurring state. This measurement also provides the industry with an easily duplicable, analytical method of testing. In addition, preliminary results show a whole fruit formula is superior to extracts for several reasons including the fact that high levels of xanthone intake results in decreased absorption efficiency, and long-term consumption of XanGo Juice results in increased levels of xanthones in the blood.
Similar news · Read more »
- Study to probe how healthy younger adults make use of genetic tests
05-03-2007 · EurekAlert!
The National Human Genome Research Institute and the National Cancer Institute, parts of the National Institutes of Health, have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions. The study is called the Multiplex Initiative.
Similar news · Read more »
- The construction of heart modelling leads path to new therapies
01-10-2008 · EurekAlert!
Heart disease is still a major killer, especially in the western world, but new therapies based on stem cells and other techniques could now be imminent. Progress is being held back however by the difficulty testing new therapies on human heart tissue, with animal models being only of limited value owing to differences in structure and activity.
Similar news · Read more »
- Updates on pandemic flu vaccine trials to be presented at 44th annual IDSA meeting
10-12-2006 · EurekAlert!
Preliminary results from clinical trials testing two different pandemic flu vaccine approaches -- one a prime-boost strategy using different subtypes of H5N1 vaccines, the other an H5N1 vaccine delivered into the skin rather than the muscle -- will be presented at the 44th Annual Meeting of the Infectious Diseases Society of America being held in Toronto on Oct. 12-15. The presentations are scheduled for a late-breaker session on Friday afternoon, Oct. 13.
Similar news · Read more »
- Rutgers biomaterial debuts in clinical trials of new stent
10-18-2007 · EurekAlert!
A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials at Rutgers University, has moved from the lab bench to field testing in record time. This achievement, a product of a breakthrough methodology in biomaterials discovery, is the enabling technology behind a coronary stent undergoing its first-in-human clinical trial in Germany and in Brazil.
Similar news · Read more »
- Using chemistry to predict the dynamics of clotting in human blood
10-16-2006 · EurekAlert!
University of Chicago chemists have demonstrated for the first time how to use a simple laboratory model consisting of only a few chemical reactions to predict when and where blood clotting will occur. The scientists used microfluidics, a technique that allowed them to probe blood clotting on surfaces that mimic vascular damage on the micron scale, a unit of measurement much narrower than the diameter of a human hair.
Similar news · Read more »
- Latest ESA Bulletin (No. 129, February 2007) now online
03-05-2007 · European Space Agency (ESA)
Global environmental change is the most fundamental challenge facing humanity. How are satellites providing the information needed for understanding the effect of increasing human activity? The two lead articles in the latest issue of ESA's magazine tackle the subject.
Similar news · Read more »
- Newly discovered proteins associated with cystic fibrosis
11-03-2006 · EurekAlert!
Researchers have found a highly unusual distribution of proteins in the lungs and airways of people with cystic fibrosis. The discovery is preliminary, but intriguing: Finding out more about the proteins could help sort out the immune system's role in the disease. The study will be presented at a meeting of the American Physiological Society, "Physiological Genomics and Proteomics of Lung Disease," on Nov. 3.
Similar news · Read more »
- OHSU turns mouse into factory for human liver cells
08-09-2007 · EurekAlert!
Oregon Health & Science University researchers have figured out how to turn a mouse into a factory for human liver cells that can be used to test how pharmaceuticals are metabolized. The technique could soon become the standard not only for examining drug metabolism in the liver, which helps scientists determine a drug's toxicity. It also can be used as a platform for testing new therapies against liver-attacking infectious diseases, including hepatitis C and malaria.
Similar news · Read more »
- Study found no drug interference with pomegranate juice
08-20-2007 · EurekAlert!
A study published in the Journal of Clinical Pharmacology finds that pomegranate juice does not interact with medication. Earlier studies suggested that, like grapefruit juice, pomegranate juice may interfere with metabolism of drugs by inhibiting CYP3A, an enzyme that allows the body to transform and eliminate a drug. This is the first study using human subjects to test the drug interactions of pomegranate juice, unlike prior studies which were conducted in vitro and in animals.
Similar news · Read more »
